134 related articles for article (PubMed ID: 7555207)
1. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
[TBL] [Abstract][Full Text] [Related]
3. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
[TBL] [Abstract][Full Text] [Related]
4. Binding of complement C3 to Klebsiella pneumoniae treated with sub-MIC cefodizime and chemiluminescence response of human polymorphonuclear leukocytes.
Nomura S; Kuroiwa A; Murata K; Nagayama A
Chemotherapy; 1997; 43(2):132-6. PubMed ID: 9084922
[TBL] [Abstract][Full Text] [Related]
5. Effects of sub-minimal inhibitory concentrations of antimicrobial agents on the cell surface of Klebsiella pneumoniae and phagocytic killing activity.
Nomura S; Murata K; Nagayama A
J Chemother; 1995 Oct; 7(5):406-13. PubMed ID: 8596121
[TBL] [Abstract][Full Text] [Related]
6. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
Braga PC; Dal Sasso M; Mancini L; Sala MT
Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
[TBL] [Abstract][Full Text] [Related]
7. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.
Labro MT; Amit N; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1987 Mar; 19(3):331-41. PubMed ID: 3032885
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
[TBL] [Abstract][Full Text] [Related]
9. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
Braga PC; Sasso MD; Sala MT
J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.
Péchinot A; Neuwirth C; Bryskier A; Duez JM; Kazmierczak A
J Antimicrob Chemother; 1997 Feb; 39(2):157-62. PubMed ID: 9069535
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
[TBL] [Abstract][Full Text] [Related]
12. Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.
Bergeron Y; Deslauriers AM; Ouellet N; Gauthier MC; Bergeron MG
Antimicrob Agents Chemother; 1999 Sep; 43(9):2291-4. PubMed ID: 10471581
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy.
Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A; Debbia E; Schito G
Chemotherapy; 1996; 42(2):100-6. PubMed ID: 8697884
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial activity of cefodizime, a third generation cephalosporin.
Pruksachatvuthi S; Aswapokee N; Aswapokee P
J Med Assoc Thai; 1992 May; 75(5):287-92. PubMed ID: 1460409
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Labro MT; el Benna J
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
[TBL] [Abstract][Full Text] [Related]
16. Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
Murgia R; Marchetti F; Cinco M
Antimicrob Agents Chemother; 1999 Dec; 43(12):3030-2. PubMed ID: 10582905
[TBL] [Abstract][Full Text] [Related]
17. [Antimicrobial activity of cefodizime against clinical isolates].
Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Deguchi K; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1996 Oct; 49(10):947-65. PubMed ID: 8986558
[TBL] [Abstract][Full Text] [Related]
18. [Influence of sub-mics of selected antibiotics on hydrophobic and adhering properties of Klebsiella pneumoniae strains isolated from urine samples].
Sekowska A; Gospodarek E; Wróblewska J
Med Dosw Mikrobiol; 2008; 60(4):297-302. PubMed ID: 19382601
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum sensitivity and hydrophobicity in a clinical isolate of Klebsiella pneumoniae treated with subinhibitory concentrations of aminoglycosides.
Hostacká A
Zentralbl Bakteriol; 1998 Dec; 288(4):519-26. PubMed ID: 9987190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
